HERON THERAPEUTICS, INC. /DE/ Deferred Tax Assets, Net
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Deferred Tax Assets, Net of $0 as of 2015-12-31, per its 10-K filed 2016-02-19.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredTaxAssetsLiabilitiesNet · last filed 2016-02-19
- 2015-12-31: Deferred Tax Assets, Net $0.00.
- 2014-12-31: Deferred Tax Assets, Net $0.00.
- 2013-12-31: Deferred Tax Assets, Net $0.00.
| Period end | Deferred Tax Assets, Net |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-19 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-19 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |